Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

 GU-CME-Banner

Join us for this in-person educational program, offered by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. The program will cover the latest strategies for optimally managing localized and advanced bladder, kidney, and prostate cancer and is presented by the Fox Chase Cancer Center genitourinary oncology team—nationally recognized physicians specializing in urology, radiation therapy, and medical oncology.

DATE

Monday, December 11, 2023

TIMES

5:45–7:00 pm – Check-in & Reception (Buffet opens at 6:30)

7:00–9:00 pm – CME & Dinner

LOCATION

Philadelphia Marriott Old City
One Dock Street
Philadelphia, PA 19106

PROGRAM DIRECTORS
Alexander Kutikov, MD, FACS
Chair and Professor, Department of Urology
Roberta R. Scheller Chair in Urologic Oncology
Fox Chase-Temple Urologic Institute provider

Daniel M. Geynisman, MD
Chief, Division of Genitourinary Medical Oncology
Associate Professor, Department of Hematology/Oncology

TOPICS & PRESENTERS

The Wolf in Sheep's Clothing: Management of Cystic Renal Masses
Randall Lee, MD

A "Living Plan" Every Day of Radiation Treatment: Adaptive Radiotherapy for Prostate Cancer
Mark Hallman, MD   

Changing Landscapes in the Treatment of Advanced Bladder Cancer 
Benjamin Miron, MD

Emerging Therapies for Treating Advanced Prostate Cancer 
Fern Anari, MD   

Advancements in Late-stage Kidney Cancer 
Pooja Ghatalia, MD 

OBJECTIVES

After participating in this educational programs, learners should be able to:

  •  Explain the newest surgical techniques for bladder, kidney, and prostate cancers.
  •  Explain the newest data and clinical trials in radiation options for advanced GU malignancies.
  •  Describe new medications and treatment options for advanced bladder, kidney, and prostate cancers.

INTENDED AUDIENCE

The program is designed for medical, surgical, and radiation oncologists; urologists; radiologists; primary care physicians; fellows; residents; nurses; and other healthcare providers.

ACCREDITATION STATEMENT

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

INQUIRIES

Lucía Tono, PhD, MEd: 215-728-3797

Lucia.Tono-Ramirez@tuhs.temple.edu

 


Published

September 22, 2023

Expires

September 22, 2025

Related Presenters

Alexander Kutikov, MD, FACS

Alexander Kutikov, MD, FACS

Chair and Professor, Department of Urology; Roberta R. Scheller Chair in Urologic Oncology; Fox Chase-Temple Urologic Institute provider

Daniel M. Geynisman, MD

Daniel M. Geynisman, MD

Chief, Division of Genitourinary Medical Oncology; Associate Professor, Department of Hematology/Oncology

Randall A. Lee, MD

Randall A. Lee, MD

Assistant Professor, Department of Urology: Fox Chase-Temple Urologic Institute provider

Mark A. Hallman, MD, PhD

Mark A. Hallman, MD, PhD

Assistant Professor, Department of Radiation Oncology

Benjamin Miron, MD

Benjamin Miron, MD

Clinical Instructor

Fern M. Anari, MD

Fern M. Anari, MD

Assistant Professor, Department of Hematology/Oncology

Pooja Ghatalia, MD

Pooja Ghatalia, MD

Assistant Professor, Department of Hematology/Oncology